Role of hydroquinone-thiol conjugates in benzene-mediated toxicity

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 212-217

  Lau, Serrine S ^a   Kuhlman, Christopher L ^a   Bratton, Shawn B ^b   Monks, Terrence J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Covalent adduction; Hematotoxicity; Hydroquinone thiol conjugates; Myleotoxicity; Protein modifications

Indexed keywords

ACETYLCYSTEINE; ARGININE; BENZENE; CYSTEINE; ERYTHROPOIETIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HYDROQUINONE DERIVATIVE; HYDROQUINONE THIOL CONJUGATE; LYSINE; PHENOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS REACTION; DNA ADDUCT; ENZYME INHIBITION; ERYTHROCYTE COUNT; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYSATE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; MALE; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BENZENE; BONE MARROW; CELL LINE; ERYTHROPOIETIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HYDROQUINONES; LYMPHOCYTE COUNT; MALE; PHENOL; RATS; SULFHYDRYL COMPOUNDS;

MUS; RATTUS;

EID: 77950627804     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.016     Document Type: Article

References (40)

1. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987, 91(1):85-95.
2. Legathe A., Hoener B.A., Tozer T.N. Pharmacokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice. Toxicol. Appl. Pharmacol. 1994, 124(1):131-138.
3. Pirozzi S.J., Schlosser M.J., Kalf G.F. Prevention of benzene-induced myelotoxicity and prostaglandin synthesis in bone marrow of mice by inhibitors of prostaglandin H synthase. Immunopharmacology 1989, 18(1):39-55.
4. Schattenberg D.G., Stillman W.S., Gruntmeir J.J., Helm K.M., Irons R.D., Ross D. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity. Mol. Pharmacol. 1994, 46(2):346-351.
5. Smart R.C., Zannoni V.G. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol. 1984, 26(1):105-111.
6. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(22):13313-13318.
7. Thomas D.J., Sadler A., Subrahmanyam V.V., Siegel D., Reasor M.J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 1990, 37(2):255-262.
8. Irons R.D. Quinones as toxic metabolites of benzene. J. Toxicol. Environ. Health 1985, 16(5):673-678.
9. Schlosser M.J., Shurina R.D., Kalf G.F. Metabolism of phenol and hydroquinone to reactive products by macrophage peroxidase or purified prostaglandin H synthase. Environ. Health Perspect. 1989, 82:229-237.
10. Subrahmanyam V.V., Doane-Setzer P., Steinmetz K.L., Ross D., Smith M.T. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 1990, 62(1):107-116.
11. Renal toxicology. Comprehensive Toxicology 1997, Elsevier Science Pub Co. I.G. Sipes, C.A. Maqueen, A.J. Gandolfi (Eds.).
12. Subrahmanyam V.V., Kolachana P., Smith M.T. Metabolism of hydroquinone by human myeloperoxidase: mechanisms of stimulation by other phenolic compounds. Arch. Biochem. Biophys. 1991, 286(1):76-84.
13. Subrahmanyam V.V., Ross D., Eastmond D.A., Smith M.T. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic. Biol. Med. 1991, 11(5):495-515.
14. Greenlee W.F., Sun J.D., Bus J.S. A proposed mechanism of benzene toxicity: formation of reactive intermediates from polyphenol metabolites. Toxicol. Appl. Pharmacol. 1981, 59(2):187-195.
15. Smith M.T., Yager J.W., Steinmetz K.L., Eastmond D.A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 1989, 82:23-29.
16. Irons R.D., Greenlee W.F., Wierda D., Bus J.S. Relationship between benzene metabolism and toxicity. A proposed mechanism for the formation of reactive intermediates from poly-phenol metabolites. Adv. Exp. Med. Biol. 1982, 136A:229.
17. Yeowell-O'Connell K., Rothman N., Smith M.T., Hayes R.B., Li G., Waidyanatha S., Dosemeci M., Zhang L., Yin S., Titenko-Holland N., Rappaport S.M. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis 1998, 19(9):1565-1571.
18. Yeowell-O'Connell K., Rothman N., Waidyanatha S., Smith M.T., Hayes R.B., Li G., Bechtold W.E., Dosemeci M., Zhang L., Yin S., Rappaport S.M. Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China. Cancer Epidemiol. Biomarkers Prev. 2001, 10(8):831-838.
19. McDonald T.A., Yeowell-O'Connell K., Rappaport S.M. Comparison of protein adducts of benzene oxide and benzoquinone in the blood and bone marrow of rats and mice exposed to [14C/13C6]benzene. Cancer Res. 1994, 54(18):4907-4914.
20. Williams K.E., Carver T.A., Miranda J.J., Kautiainen A., Vogel J.S., Dingley K., Baldwin M.A., Turteltaub K.W., Burlingame A.L. Attomole detection of in vivo protein targets of benzene in mice: evidence for a highly reactive metabolite. Mol. Cell. Proteomics 2002, 1(11):885-895.
21. Lau S.S., Hill B.A., Highet R.J., Monks T.J. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 1988, 34(6):829-836.
22. Bratton S.B., Lau S.S., Monks T.J. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 1997, 10(8):859-865.
23. Kleiner H.E., Jones T.W., Monks T.J., Lau S.S. Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity. Chem. Res. Toxicol. 1998, 11(11):1291-1300.
24. Labenski M.T., Fisher A.A., Lo H.H., Monks T.J., Lau S.S. Protein electrophile-binding motifs: lysine-rich proteins are preferential targets of quinones. Drug Metab. Dispos. 2009, 37(6):1211-1218.
25. Fisher A.A., Labenski M.T., Malladi S., Gokhale V., Bowen M.E., Milleron R.S., Bratton S.B., Monks T.J., Lau S.S. Quinone electrophiles selectively adduct " electrophile binding motifs" within cytochrome c. Biochemistry 2007, 46(39):11090-11100.
26. Kleiner H.E., Rivera M.I., Pumford N.R., Monks T.J., Lau S.S. Immunochemical detection of quinol-thioether-derived protein adducts. Chem. Res. Toxicol. 1998, 11(11):1283-1290.
27. Roede J.R., Stewart B.J., Petersen D.R. Decreased expression of peroxiredoxin 6 in a mouse model of ethanol consumption. Free Radic. Biol. Med. 2008, 45(11):1551-1558.
28. Lau S.S., Monks T.J., Everitt J.I., Kleymenova E., Walker C.L. Carcinogenicity of a nephrotoxic metabolite of the " nongenotoxic" carcinogen hydroquinone. Chem. Res. Toxicol. 2001, 14(1):25-33.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76(9):4350-4354.
30. Baruchel S., Bernstein M., Whitehead V.M., Devine S., Bell B., Dubowy R., Grier H., Kretschmar C., Langevin A.M., Vietti T. A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group study. Invest New Drugs 1995, 13(3):211-216.
31. Earhart R.H., Khandekar J.D., Faraggi D., Schinella R.A., Davis T.E. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest. New Drugs 1989, 7(2/3):255-260.
32. Maroun J.A., Stewart D.J., Verma S., Evans W.K., Eisenhauer E. Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study. Am. J. Clin. Oncol. 1990, 13(5):401-404.
33. Dethmers J.K., Meister A. Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(12):7492-7496.
34. van den Dobblesteen D.J., Nobel C.S.I., Slater A.F., Orrenius S. Regulation and mechanisms of apoptosis in T lymphocytes. Arch. Toxicol. (Suppl.) 1996, 19:77-85.
35. Bratton S.B., Lau S.S., Monks T.J. The putative benzene metabolite 2, 3, 5-tris(glutathion-S-yl)hydroquinone depletes glutathione, stimulates sphingomyelin turnover, and induces apoptosis in HL-60 cells. Chem. Res. Toxicol. 2000, 13(7):550-556.
36. Blanchard K.L., Acquaviva A.M., Galson D.L., Bunn H.F. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell Biol. 1992, 12(12):5373-5385.
37. Groopman J.E., Molina J.M., Scadden D.T. Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med. 1989, 321(21):1449-1459.
38. Hill B.A., Lo H.H., Monks T.J., Lau S.S. The role of gamma-glutamyl transpeptidase in hydroquinone-glutathione conjugate mediated nephrotoxicity. Adv. Exp. Med. Biol. 1991, 283:749-751.
39. Stewart B.J., Doorn J.A., Petersen D.R. Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. Chem. Res. Toxicol. 2007, 20(8):1111-1119.
40. Petersen D.R., Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 2004, 37(7):937-945.